STAGE III RECTAL CANCER AJCC V7
Clinical trials for STAGE III RECTAL CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III RECTAL CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE III RECTAL CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise for advanced rectal cancer
Disease control CompletedThis study tested whether adding either veliparib or pembrolizumab to standard chemotherapy and radiation could improve outcomes for people with locally advanced rectal cancer. 363 participants received one of these combinations before surgery. The goal was to shrink tumors more …
Matched conditions: STAGE III RECTAL CANCER AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 18, 2026 11:52 UTC
-
New hope for Hard-to-Treat colorectal cancer: targeted therapy showdown
Disease control CompletedThis study tested two different drug combinations in 240 people with advanced colorectal cancer that has a specific genetic change called HER2 amplification. One group received a combination of targeted antibodies (trastuzumab and pertuzumab), while the other received a standard …
Matched conditions: STAGE III RECTAL CANCER AJCC V7
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 11, 2026 12:12 UTC